Medicare Enrolled
Dr. Mohamed Faher Almahmoud, M.D., MS
Interventional Cardiology · Kingwood, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Almahmoud from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Almahmoud? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Almahmoud
Dr. Mohamed Faher Almahmoud is an interventional cardiology in Kingwood, TX, with 14 years in practice. Based on federal Medicare data, Dr. Almahmoud performed 4,365 Medicare services across 1,990 unique beneficiaries.
Between the years covered by Open Payments, Dr. Almahmoud received a total of $19,778 from 41 pharmaceutical and/or device companies across 285 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Almahmoud is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice▲ Top 19% volume in TX$ $19,778 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,365
Medicare services
Top 19% in TX for interventional cardiology
1,990
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~312 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 651 | $31 | $126 |
| EKG interpretation and report | 509 | $6 | $35 |
| Hospital follow-up visit, high complexity | 410 | $96 | $315 |
| Office visit, established patient (30-39 min) | 376 | $93 | $400 |
| Remote patient monitoring management, 20 min/month | 354 | $39 | $155 |
| Remote patient monitoring device, 30 days | 299 | $40 | $172 |
| Electrocardiogram (EKG), 12-lead | 263 | $11 | $60 |
| Chronic care management, additional 20 min/month | 213 | $38 | $150 |
| Regadenoson injection (Lexiscan) for heart stress test | 196 | $33 | $209 |
| Initial hospital admission, high complexity | 127 | $136 | $610 |
| Chronic care management, first 20 min/month | 116 | $50 | $198 |
| Echocardiogram, transthoracic | 76 | $143 | $850 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 72 | $30 | $855 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 51 | $665 | $2,814 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 50 | $10 | $161 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 50 | $626 | $849 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 49 | $56 | $400 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 49 | $20 | $80 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 48 | $1,893 | $5,742 |
| Nuclear medicine study of heart muscle blood flow by pet | 48 | $143 | $433 |
| Ultrasound of leg arteries or artery grafts | 47 | $190 | $820 |
| Office visit, established patient, complex (40-54 min) | 46 | $135 | $564 |
| Ultrasound of both sides of head and neck blood flow | 44 | $126 | $800 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 41 | $15 | $59 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 33 | $132 | $650 |
| Cardiac catheterization | 32 | $162 | $909 |
| Ultrasonic guidance for blood vessel access | 19 | $11 | $43 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $2 | $10 |
| Ultrasound study of arm and leg arteries | 16 | $67 | $262 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $5 | $23 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $45 | $175 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $83 | $335 |
| New patient office visit, complex (60-74 min) | 12 | $143 | $690 |
| Ultrasound of heart, follow-up | 11 | $18 | $78 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.2% high complexity
11.5% medium
85.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,778
Total received (2018-2024)
Avg $2,825/year across 7 years
Top 23% in TX for interventional cardiology
41
Companies
285
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,778 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,555
2023$1,690
2022$4,403
2021$2,787
2020$2,252
2019$1,022
2018$2,068
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$3,093
Penumbra, Inc.
$3,003
Abbott Laboratories
$2,419
Medtronic Vascular, Inc.
$2,066
Boston Scientific Corporation
$1,458
Impulse Dynamics (USA) Inc.
$1,442
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$825
BOSTON SCIENTIFIC CORPORATION
$711
AstraZeneca Pharmaceuticals LP
$439
Inari Medical, Inc.
$356
Amgen Inc.
$318
ABIOMED
$302
Novo Nordisk Inc
$302
AngioDynamics, Inc.
$301
Janssen Pharmaceuticals, Inc
$251
BIOTRONIK INC.
$225
Siemens Medical Solutions USA, Inc.
$223
Cardiovascular Systems Inc.
$215
Chiesi USA, Inc.
$188
Merck Sharp & Dohme LLC
$164
Novartis Pharmaceuticals Corporation
$157
Tactile Systems Technology Inc
$151
ZOLL Circulation Inc
$145
Veryan Medical Incorporated
$144
Boehringer Ingelheim Pharmaceuticals, Inc.
$122
SANOFI-AVENTIS U.S. LLC
$114
Philips North America LLC
$112
Kestra Medical Technology Services, Inc.
$102
Becton, Dickinson and Company
$100
E.R. Squibb & Sons, L.L.C.
$47
Esperion Therapeutics, Inc.
$40
Bard Peripheral Vascular, Inc.
$35
Cook Medical LLC
$35
PFIZER INC.
$28
Merck Sharp & Dohme Corporation
$27
CVRx, Inc.
$27
Edwards Lifesciences Corporation
$27
Shockwave Medical, Inc
$20
ARBOR PHARMACEUTICALS, INC.
$20
Teleflex LLC
$14
CashFlow Solutions, LLC
$13
Top 3 companies account for 43.1% of total payments
Associated products mentioned in payments ›
(BH4) IGT Devices Undivided · AMPLATZER Occluders · AURYON LASER SYSTEM 100-120 VAC · AVVIGO Guidance System · Assure WCD · BRILINTA · Barostim Neo System · BioMimics 3D Vascular Stent System · BodyGuardian · CARDIOMEMS · CFN ChloraPrep · COBALT DR MRI SURESCAN · COOK CELECT · COREVALVE EVOLUT R · CardioMEMS HF System · CorPath Imaging System · CoreValve Evolut · Coronary Orbital Atherectomy System · Dragonfly OCT · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edarbyclor · FARXIGA · FLOWTRIEVER CATHETER · Flexitouch Plus · GENERAL - ATHERECTOMY · GENERAL - VASCULAR INTERVENTION · GENERAL BRADY · GENERAL TACHY · Impella · Indigo System · JARDIANCE · KENGREAL · LEQVIO · LYMPHA PRESS OPTIMAL PLUS(US) BT · LifeVest · MICRA · MINI TREK · MITRACLIP · MULTAQ · NEXLETOL · ONYX FRONTIER · OPTICROSS · OPTIMIZER · Optimizer · Optis Coronary Imaging System · Ozempic · PCI Optimization · PERCLOSE PROGLIDE · PRALUENT · REVEAL LINQ · RHYTHMIA · Repatha · Resolute · Rotarex · Rybelsus · S · SYNERGY · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TORCON NB · TURBOHAWK · TURNPIKE · Temperature Management System · TherOx DS2 Console · VENASEAL · VERQUVO · Varithena Administration Pack · Vascular Lithotripsy · VenaCure 1470 Pro · VenaSeal · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · Xience Sierra Coronary Stent
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $453 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
31
Per 100K population
0.7
County median income
$73,104
Nearest hospital
KINGWOOD PINES HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Almahmoud is a clinical cardiology specialist, with above-average Medicare volume (top 19% in TX), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Almahmoud experienced with management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes?
Based on Medicare claims data, Dr. Almahmoud performed 651 management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Almahmoud receive payments from pharmaceutical companies?
Yes. Dr. Almahmoud received a total of $19,778 from 41 companies across 285 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Almahmoud's costs compare to other interventional cardiologys in Kingwood?
Dr. Almahmoud's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Almahmoud) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Kingwood
Browse interventional cardiologys in Kingwood ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in TX
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in TX
Which TX interventional cardiologys receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology